14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 CLRB stock ended at $3.42. This is 2.40% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.09% from a day low at $3.34 to a day high of $3.51.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
Feb 23, 2023 $1.55 $1.61 $1.52 $1.58 28 105
Feb 22, 2023 $1.56 $1.58 $1.51 $1.52 50 367
Feb 21, 2023 $1.60 $1.70 $1.55 $1.59 72 397
Feb 17, 2023 $1.67 $1.68 $1.59 $1.67 16 773
Feb 16, 2023 $1.66 $1.73 $1.61 $1.63 54 971
Feb 15, 2023 $1.65 $1.68 $1.61 $1.67 41 075
Feb 14, 2023 $1.74 $1.74 $1.64 $1.67 23 097
Feb 13, 2023 $1.71 $1.79 $1.65 $1.72 46 965
Feb 10, 2023 $1.72 $1.72 $1.65 $1.70 37 757
Feb 09, 2023 $1.87 $1.87 $1.69 $1.70 37 201
Feb 08, 2023 $1.90 $1.95 $1.71 $1.73 112 131
Feb 07, 2023 $1.76 $2.05 $1.70 $1.90 188 453
Feb 06, 2023 $1.60 $1.71 $1.58 $1.70 42 121
Feb 03, 2023 $1.64 $1.68 $1.61 $1.65 27 310
Feb 02, 2023 $1.47 $1.61 $1.47 $1.61 48 616
Feb 01, 2023 $1.46 $1.53 $1.46 $1.52 33 216
Jan 31, 2023 $1.58 $1.62 $1.47 $1.51 45 479
Jan 30, 2023 $1.56 $1.69 $1.53 $1.58 66 727
Jan 27, 2023 $1.51 $1.57 $1.48 $1.54 32 220
Jan 26, 2023 $1.51 $1.56 $1.44 $1.49 43 187
Jan 25, 2023 $1.55 $1.55 $1.43 $1.48 38 033
Jan 24, 2023 $1.61 $1.61 $1.49 $1.55 30 065
Jan 23, 2023 $1.54 $1.60 $1.49 $1.60 71 191
Jan 20, 2023 $1.50 $1.53 $1.42 $1.51 80 515
Jan 19, 2023 $1.51 $1.58 $1.45 $1.48 31 704
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT